Today: 19 May 2026
Salesforce stock sinks as ‘software-mageddon’ bites again — what to watch before earnings
6 February 2026
2 mins read

Salesforce stock sinks as ‘software-mageddon’ bites again — what to watch before earnings

New York, Feb 5, 2026, 17:37 EST — After-hours

  • On Thursday, Salesforce shares dropped 4.8%, ending the day just below $190
  • Software shares remained under pressure amid concerns that AI might upend subscription-based revenue models
  • All eyes now shift to Salesforce’s February 25 earnings report as the next key catalyst

Shares of Salesforce Inc (CRM) dropped 4.8% on Thursday, closing at $189.97. The stock swung between $187.80 and $200.40, with roughly 21.9 million shares changing hands.

Salesforce tumbled alongside other software-as-a-service (SaaS) stocks as investors dumped subscription cloud apps amid concerns that rapid advances in AI could undercut demand and pricing power. The S&P 500 software and services index plunged 4.6%, pushing its year-to-date loss to roughly 16.5%, deepening what traders are now dubbing a “software-mageddon.” Dave Harrison Smith, CIO at Bailard, called it a “sell-everything mindset,” while Reuters reported rising short interest in mid- and large-cap software names. Reuters

The stock plunged about $9.55, ranking among the top decliners on the Dow as it fell over 500 points. Salesforce and Amazon alone shaved roughly 117 points from the price-weighted index, according to MarketWatch’s analysis.

The selloff has spread worldwide, as investors in Europe and Asia offload software stocks while weighing if new AI tools can replace tasks traditionally handled by costly software suites. A Guardian market live blog linked this week’s drop to renewed excitement about Anthropic’s AI offerings for legal work.

Salesforce announced Wednesday it will report fourth-quarter and full-year fiscal 2026 results on Feb. 25, after the U.S. market closes. A conference call is set for 5 p.m. ET that day. Traders are now focused on whether the company’s AI initiatives are moving beyond pilot stages to actual paid adoption.

On Thursday, Salesforce released its annual Connectivity Benchmark Report, revealing that companies currently use an average of 12 AI agents and anticipate that figure will jump 67% over the next two years. Andrew Comstock, a MuleSoft executive, emphasized that success doesn’t come from the number of agents deployed but from how they’re governed and coordinated. Deloitte’s Kurt Anderson stressed the importance of “moving from simply deploying agents to operationalizing them at scale.” Salesforce

Salesforce’s Agentforce 360 made waves in customer marketing this week. LIV Golf announced its broadcasts will feature an AI “Agent Caddie” called Chip, delivering predictive shot outcomes and player stats straight to on-air analysts. Salesforce

Some bulls on Wall Street are already sniffing out a bottom. Wedbush analyst Dan Ives dismissed the sector’s selloff as a “garage sale,” telling Business Insider that investors are fixated on a near-term “doomsday scenario.” He remains bullish on Salesforce, keeping it on his buy list with a $375 price target. The stock has fallen more than 21% so far this year, he noted.

Value investors are showing interest, at least on paper. Barron’s reports that Salesforce is now trading with a forward price-to-earnings ratio below 15. This valuation, based on expected profits, is not only lower than its historical norm but also undercuts the broader S&P 500.

Yet what comes next hinges on the data, not the storylines. Should Salesforce’s guidance fall short or clients delay major CRM deployments, shares might face steeper declines—especially as discussions around AI disruption continue to expand.

Traders are now focused on whether software stocks can find footing as Friday’s session unfolds and if the recent selloff prompts more analysts to lower their estimates. Salesforce’s next major event comes Feb. 25, when it releases earnings after the market closes and fields investor questions about demand trends and its AI strategy.

Stock Market Today

  • India IPO Fundraising Drops to Two-Year Low in Early 2026 with Uncertain Outlook for H2
    May 19, 2026, 6:19 AM EDT. India's IPO fundraising has plunged to Rs 56,322 crore in the first five months of 2026, marking a sharp decline from Rs 82,678 crore in the same period last year and a two-year low, according to Primedatabase. Contributing factors include market volatility, geopolitical tensions, and cautious investor behavior amid global uncertainties. Notably, average subscription rates fell to roughly 2x in early 2026 from 38x in H2 2025, signaling weakened appetite. Despite a healthy pipeline with major listings from NSE and Jio Platforms expected in the second half, experts warn recovery will be cautious and selective. Institutional investors now favor profitable, scalable firms over aggressive growth models. The primary market slowdown contrasts with record 2025 fundraising and raises concerns about H2 momentum.

Latest articles

Hesai Up Premarket After Mercedes Lidar Win, Q1 Profit

Hesai Up Premarket After Mercedes Lidar Win, Q1 Profit

19 May 2026
Hesai Group shares rose 2.68% to $22.60 in U.S. premarket trading after reporting a first-quarter profit and confirming it will supply lidar sensors for Mercedes-Benz Level 3 autonomous models. The company shipped 471,723 lidar units, up 140.9% year-on-year, and posted revenue of RMB680.6 million ($98.7 million). Net income reached RMB18.3 million, reversing a loss from a year earlier.
Virax Biolabs Shares Jumping Again Ahead of Nasdaq Open

Virax Biolabs Shares Jumping Again Ahead of Nasdaq Open

19 May 2026
Virax Biolabs shares surged 53.1% Monday to $0.2350 and climbed another 17.1% in early Tuesday premarket trading, hitting $0.2751. The rally followed a paid RedChip TV appearance and a May 15 ownership filing showing Armistice Capital with a 4.99% stake. No new clinical or product updates were posted. Trading volume Monday reached about 765.2 million shares.
Amesite Shares Rise Premarket After NurseMagic Signs Largest Client

Amesite Shares Rise Premarket After NurseMagic Signs Largest Client

19 May 2026
Amesite Inc. shares surged 218% to $2.50 in premarket trading after announcing its largest NurseMagic deployment with a 2,700-patient home-care client. The company disclosed $83,332 in quarterly revenue and a $678,061 net loss, with cash at $740,711 before a $2.2 million April financing. Amesite did not reveal the new contract’s value or customer name. Its latest filing cited “substantial doubt” about ongoing operations.

Popular

Nasdaq gives up after-hours gains as oil and yields weigh on Wall Street rally

Nasdaq gives up after-hours gains as oil and yields weigh on Wall Street rally

19 May 2026
Dominion Energy shares jumped 9.4% after agreeing to an all-stock merger with NextEra Energy, whose shares fell 4.6%. The S&P 500 slipped 0.1% and the Nasdaq dropped 0.5% as investors sold technology stocks amid rising Treasury yields and oil prices. Nvidia fell 1.4% ahead of earnings. U.S. crude settled at $107.37, and the 10-year Treasury yield reached 4.59%.
S&P Global stock slides again as “Mobility Global” spin-off rebrand puts SPGI in the spotlight
Previous Story

S&P Global stock slides again as “Mobility Global” spin-off rebrand puts SPGI in the spotlight

AppLovin stock price slips after hours as CloudX launch and Wedbush target cut put Feb. 11 earnings in play
Next Story

AppLovin stock price slips after hours as CloudX launch and Wedbush target cut put Feb. 11 earnings in play

Go toTop